Frazier Life Sciences Management, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001892134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 51 positions · Total reported value $1.50B · Top-10 concentration 63.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 22.7% · 6 new · 1 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +20.6% · vs SPY +5.8% · Prev Value $3.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, Frazier Life Sciences Management, L.P. disclosed 51 equity positions with a combined reported value of $1.50B. The filing implies a focused portfolio: its ten largest positions account for 63.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were MIRM ($204.46M), HLVX ($131.56M), KRYS ($114.66M). By sector, the heaviest allocations are Health Care 73.2%, Materials 0.1%.

Versus the prior quarter, Frazier Life Sciences Management, L.P. opened 6 new positions, trimmed 1 and fully exited 3, a turnover rate of 22.7% of positions.

The largest new positions opened in Q3 2023 were MIRM ($204.46M), HLVX ($131.56M), KRYS ($114.66M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • MIRM MIRUM PHARMACEUTICALS INC · $204.46M
  • HLVX HILLEVAX INC · $131.56M
  • KRYS KRYSTAL BIOTECH INC · $114.66M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $112.22M
  • PHAT PHATHOM PHARMACEUTICALS INC · $104.83M
  • BBIO BRIDGEBIO PHARMA INC · $71.88M
  • PCVX VAXCYTE INC · $59.36M
  • RYTM RHYTHM PHARMACEUTICALS INC · $54.36M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Frazier Life Sciences Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Frazier Life Sciences Management, L.P. is an SEC-registered 13F filer. As of Q2 2026 it reported 41 US equity positions with a combined value of $4.59B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 41 positions · $4.59B reported value (Q2 2026)
  • Top 10 holdings = 73.6% of reported value
  • Largest position: MIRM (MIRUM PHARMACEUTICALS INC) at 19.6%
  • Average position size: $112.00M

Sector Tilt

  • Health Care 99.8%
  • Materials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 8 added, 1 reduced, 3 exited
  • 26 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.2%
Materials 0.1%
Other 26.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.47M $204.46M 13.66%
13.66%
New
2 9.78M $131.56M 8.79%
8.79%
New
3 988.46K $114.66M 7.66%
7.66%
New
4 12.13M $112.22M 7.50%
7.50%
New
5 10.11M $104.83M 7.00%
7.00%
New
6 2.73M $71.88M 4.80%
4.80%
New
7 1.16M $59.36M 3.96%
3.96%
New
8 2.37M $54.36M 3.63%
3.63%
New
9 3.01M $49.13M 3.28%
3.28%
New
10 1.59M $47.28M 3.16%
3.16%
New
11 8.68M $46.11M 3.08%
3.08%
New
12 2.99M $34.19M 2.28%
2.28%
New
13 1.79M $31.76M 2.12%
2.12%
New
14 3.24M $31.19M 2.08%
2.08%
New
15 655.00K $30.77M 2.06%
2.06%
New
16 1.40M $28.75M 1.92%
1.92%
New
17 997.46K $27.61M 1.84%
1.84%
New
18 614.04K $23.36M 1.56%
1.56%
New
19 1.39M $22.33M 1.49%
1.49%
New
20 746.48K $17.60M 1.18%
1.18%
New
21 1.20M $16.35M 1.09%
1.09%
New
22 899.70K $16.16M 1.08%
1.08%
New
23 4.00M $15.12M 1.01%
1.01%
New
24 6.88M $15.00M 1.00%
1.00%
New
25 1.50M $14.64M 0.98%
0.98%
New
26 1.05M $14.35M 0.96%
0.96%
New
27 1.03M $14.16M 0.95%
0.95%
New
28 464.94K $13.72M 0.92%
0.92%
New
29 630.90K $13.15M 0.88%
0.88%
New
30 2.14M $12.96M 0.87%
0.87%
New
31 3.75M $8.73M 0.58%
0.58%
New
32 881.17K $8.66M 0.58%
0.58%
New
33 393.00K $8.58M 0.57%
0.57%
New
34 400.00K $8.52M 0.57%
0.57%
New
35 1.80M $8.40M 0.56%
0.56%
New
36 292.00K $7.23M 0.48%
0.48%
New
37 386.76K $6.62M 0.44%
0.44%
New
38 203.68K $6.44M 0.43%
0.43%
New
39 127.90K $6.17M 0.41%
0.41%
New
40 2.25M $6.05M 0.40%
0.40%
New
41 285.33K $5.60M 0.37%
0.37%
New
42 1.71M $5.20M 0.35%
0.35%
New
43 849.02K $4.86M 0.33%
0.33%
New
44 370.00K $4.71M 0.31%
0.31%
New
45 780.00K $2.71M 0.18%
0.18%
New
46 1.43M $2.46M 0.16%
0.16%
New
47 264.38K $1.81M 0.12%
0.12%
New
48 600.00K $1.57M 0.10%
0.10%
New
49 1.65M $1.48M 0.10%
0.10%
New
50 1.76M $1.16M 0.08%
0.08%
New

FAQ

What did Frazier Life Sciences Management, L.P. buy in 2023-Q3?

In its 2023-Q3 13F filing, Frazier Life Sciences Management, L.P. reported 51 equity positions worth $1.50B in aggregate; its largest disclosed positions were MIRM ($204.46M), HLVX ($131.56M), KRYS ($114.66M).

How large is Frazier Life Sciences Management, L.P.'s portfolio?

Frazier Life Sciences Management, L.P. reported $1.50B of long equity holdings across 51 positions as of 2023-Q3. Top-10 holdings account for 63.4% of reported value.

What is Frazier Life Sciences Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/frazier-life-sciences-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →